𝛼SK or Searchbullish
Seegene (096530 KQ/Buy)In-Vitro Diagnostic Revenue of W500bn Within Reach
In-vitro diagnostic revenue of W500bn within reach4Q25 review: Revenue meets consensus; OP misses For 4Q25, Seegene posted revenue of W130
What is covered in the Full Insight:
- Financial Overview for 4Q25
- Revenue and Profit Analysis
- Growth Drivers and Challenges
- Valuation and Market Position
- Forecast and Recommendations
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 19-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Seegene (096530 KQ/Buy)In-Vitro Diagnostic Revenue of W500bn Within Reach03 Mar 2026
x